One important finding of the present study is that SKI-349 downregulated BRD4 and inhibited BRD4-dependent genes (Myc, cyclin D1 and Klf4) in primary NSCLC cells (Fig. 6N). This evidence concerns the gene BRD4 and non-small cell lung carcinoma.